Imperial College London

DrPaulVerschueren

Faculty of Natural SciencesDepartment of Mathematics

Academic Visitor
 
 
 
//

Contact

 

p.verschueren

 
 
//

Location

 

Huxley BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Vandormael:2022:10.1136/annrheumdis-2022-eular.2388,
author = {Vandormael, P and Pues, A and Sleurs, E and Liesenborgs, J and Verschueren, P and Somers, V},
doi = {10.1136/annrheumdis-2022-eular.2388},
pages = {299--299},
publisher = {BMJ PUBLISHING GROUP},
title = {NOVEL ANTIBODY BIOMARKERS THAT PREDICT FAILURE TO ACHIEVE EARLY AND SUSTAINED DISEASE REMISSION OR LOW DISEASE ACTIVITY AFTER INTENSIVE FIRST-LINE THERAPY IN RHEUMATOID ARTHRITIS},
url = {http://dx.doi.org/10.1136/annrheumdis-2022-eular.2388},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Vandormael,P
AU - Pues,A
AU - Sleurs,E
AU - Liesenborgs,J
AU - Verschueren,P
AU - Somers,V
DO - 10.1136/annrheumdis-2022-eular.2388
EP - 299
PB - BMJ PUBLISHING GROUP
PY - 2022///
SN - 0003-4967
SP - 299
TI - NOVEL ANTIBODY BIOMARKERS THAT PREDICT FAILURE TO ACHIEVE EARLY AND SUSTAINED DISEASE REMISSION OR LOW DISEASE ACTIVITY AFTER INTENSIVE FIRST-LINE THERAPY IN RHEUMATOID ARTHRITIS
UR - http://dx.doi.org/10.1136/annrheumdis-2022-eular.2388
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000850279001084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -